In September this year, there was a surplus of AstraZeneca vaccine in Canada with an expiry date around December. So it was important to offer these 760 or so doses. We asked countries fairly close to Canada, countries in Latin America and the Caribbean, if they needed vaccine and they seemed interested.
In these circumstances, these countries—I have forgotten the exact list—accepted these doses. However, for a capacity reason, as I recall, Haiti was not in a position at that time to accept these surpluses.